Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.6 USD | -0.60% | -1.74% | +12.35% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
Chart calendar Blueprint Medicines Corporation
Upcoming events on Blueprint Medicines Corporation
Past events on Blueprint Medicines Corporation
2024-05-13 10:00 am | Citizens JMP Life Sciences Conference |
2024-05-02 08:00 am | Q1 2024 Earnings Call |
2024-05-02 07:00 am | Q1 2024 Earnings Release |
2024-04-25 10:00 am | Business Update Call |
2024-03-04 09:10 am | TD Cowen Health Care Conference |
2024-02-25 04:45 pm | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 783 |
2024-02-25 02:25 pm | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 739 |
2024-02-25 02:15 pm | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 737 |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 691 |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 692 |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 696 |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 693 |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No - 689 |
2024-02-23 03:15 pm | American Academy of Allergy Asthma & Immunology Meeting - Abstract No - 189 |
2024-02-15 08:00 am | Q4 2023 Earnings Call |
2024-02-15 07:00 am | Q4 2023 Earnings Release |
2024-01-08 01:30 pm | JPMorgan Healthcare Conference |
2023-12-10 09:00 am | American Society of Hematology Meeting - Abstract No: 3800 |
2023-12-09 01:15 pm | American Society of Hematology Meeting - Abstract No: 76 |
2023-12-09 01:00 pm | American Society of Hematology Meeting - Abstract No: 75 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 66,5 41,4 60.62% | 794 789 0.62% | 180 177 2.01% | 204 199 2.78% | 249 245 1.79% | 431 |
EBITDA Million USD | Released Forecast Spread | -356 -350 -1.72% | 315 327 -3.49% | -636 -430 -47.7% | -526 -535 1.68% | -475 -498 4.62% | -290 |
EBIT Million USD | Released Forecast Spread | -361 -374 3.33% | 309 252 22.59% | -642 -428 -49.91% | -538 -544 1.15% | -486 -501 2.95% | -288 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -348 -364 4.55% | 315 313 0.76% | -641 -423 -51.41% | -552 -552 -0.03% | -506 -519 2.55% | -162 |
Net income Million USD | Released Forecast Spread | -348 -366 5.02% | 314 311 0.91% | -644 -413 -55.85% | -558 -559 0.21% | -507 -520 2.47% | -152 |
EPS USD | Released Forecast Spread | -7,27 -7,71 5.68% | 5,59 5,48 1.98% | -11,0 -7,04 -56.47% | -9,35 -9,35 -0.01% | -8,37 -8,58 2.45% | -2,23 |
Announcement Date | 13/02/20 | 17/02/21 | 16/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 62,7 40,0 56.89% | 36,5 37,6 -2.83% | 66,0 43,9 50.37% | 38,8 33,5 15.69% | 63,3 41,9 51.21% | 57,6 45,6 26.24% | 56,6 50,7 11.68% | 72,0 67,1 7.23% | 96,1 81,4 18.01% | 103 | 112 | 121 | 132 | 143 |
EBITDA Million USD | Released Forecast Spread | -104 -103 -1.17% | -156 -129 -21.06% | -123 -155 20.91% | -143 -151 5.44% | -121 -172 29.93% | -124 -155 19.74% | -126 -163 22.63% | -104 -117 11.47% | -74,0 -95,0 22.09% | -77,0 | -75,1 | -62,7 | -55,3 | -45,4 |
EBIT Million USD | Released Forecast Spread | -106 -115 7.87% | -158 -133 -18.73% | -124 -150 16.96% | -150 -156 4.05% | -124 -157 20.65% | -128 -150 14.69% | -129 -140 7.61% | -105 -119 11.83% | -78,8 -94,7 16.8% | -76,1 | -69,1 | -63,6 | -50,3 | -41,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -106 -114 7.21% | -157 -130 -20.8% | -132 -150 11.59% | -158 -158 0.09% | -129 -160 19.49% | -133 -154 13.87% | -134 -146 8.47% | -111 -124 10.4% | 89,3 -101 188.01% | -84,0 | -77,7 | -73,8 | -58,2 | -49,0 |
Net income Million USD | Released Forecast Spread | -106 -112 5.52% | -160 -132 -21.34% | -133 -151 11.58% | -159 -160 1.06% | -130 -161 19.4% | -133 -153 13.3% | -134 -145 7.81% | -111 -125 11% | 89,1 -101 188.19% | -82,4 | -75,5 | -70,4 | -58,2 | -49,8 |
EPS USD | Released Forecast Spread | -1,79 -1,89 5.15% | -2,68 -2,23 -20.35% | -2,23 -2,51 11.29% | -2,65 -2,67 0.64% | -2,15 -2,66 19.2% | -2,19 -2,53 13.56% | -2,20 -2,39 7.76% | -1,82 -2,04 10.88% | 1,40 -1,65 184.98% | -1,32 | -1,21 | -1,12 | -0,93 | -0,79 |
Announcement Date | 03/05/22 | 02/08/22 | 01/11/22 | 16/02/23 | 04/05/23 | 02/08/23 | 26/10/23 | 15/02/24 | 02/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Blueprint Medicines Corporation
Today | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
Today | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BPMC Stock
- Calendar Blueprint Medicines Corporation